TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting
April 22, 2024 02:00 ET
|
TVM Life Science Management GmbH
MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
TVM Capital Life Science to Participate in LSI USA ’24 Emerging Medtech Summit 2024
March 13, 2024 10:00 ET
|
TVM Life Science Management GmbH
TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science Co-Leads $16 Million Series A Financing Round for Vektor Medical to Revolutionize Arrhythmia Care
February 06, 2024 04:07 ET
|
TVM Life Science Management GmbH
MUNICH, Germany and MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App
January 31, 2024 04:00 ET
|
TVM Life Science Management GmbH
MUNICH, Germany and MONTREAL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation,...
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
July 20, 2023 08:00 ET
|
TVM Life Science Management GmbH
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to...
TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
March 17, 2023 09:00 ET
|
TVM Life Science Management GmbH
MONTREAL and MUNICH, Germany, March 17, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
February 23, 2023 08:00 ET
|
TVM Life Science Management GmbH
MONTREAL, Canada and MUNICH, Germany, Feb. 23, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences...
TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
February 08, 2023 08:00 ET
|
TVM Life Science Management GmbH
LAmAb Biologics to develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases LAmAb Biologics is the 9th early-stage or product focused...
TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
February 01, 2023 08:00 ET
|
TVM Life Science Management GmbH
Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-001 delivered in...